BACKGROUND: The AJCC staging system and post-operative nomograms use patient and tumor characteristics to provide prognostic estimates after resection of retroperitoneal sarcoma (RPS). While these variables help to predict survival at the time of diagnosis and resection, the applicability of these prognostic factors to survivors of RPS remains unknown. We hypothesized that the variables evaluated in the current staging system and post-operative nomograms would have limited ability to predict conditional survival in patients surgically treated for RPS. METHODS: A retrospective study was conducted using National Cancer Institute-sponsored tumor registries. We identified 1,199 patients who underwent surgical resection for non-metastatic RPS from 1988 to 2007. Conditional survival was defined as time-specific estimates conditioned on living a certain number of years post-diagnosis. Cox proportional hazards regression was used to assess the impact of various factors on sarcoma-specific survival (SSS) at baseline and up to 5 years after diagnosis. RESULTS: Older age, male gender, histologic subtype, and high tumor grade predicted worse SSS at the time of diagnosis. After 1 year of survival, older age, male gender, and histologic subtype were no longer significant predictors of conditional survival. Only high grade tumors remained a significant predictor of worse prognosis after 5 years of survival (HR 1.95). CONCLUSIONS: This population-based study demonstrates that the factors which are predictive of survival at baseline lose significance after one year of survival. Conditional survival estimates allow clinicians to provide survivors with more meaningful prognostic estimates that may impact surveillance schedules and streamline adjuvant therapy decisions and design of future clinical trials.
BACKGROUND: The AJCC staging system and post-operative nomograms use patient and tumor characteristics to provide prognostic estimates after resection of retroperitoneal sarcoma (RPS). While these variables help to predict survival at the time of diagnosis and resection, the applicability of these prognostic factors to survivors of RPS remains unknown. We hypothesized that the variables evaluated in the current staging system and post-operative nomograms would have limited ability to predict conditional survival in patients surgically treated for RPS. METHODS: A retrospective study was conducted using National Cancer Institute-sponsored tumor registries. We identified 1,199 patients who underwent surgical resection for non-metastatic RPS from 1988 to 2007. Conditional survival was defined as time-specific estimates conditioned on living a certain number of years post-diagnosis. Cox proportional hazards regression was used to assess the impact of various factors on sarcoma-specific survival (SSS) at baseline and up to 5 years after diagnosis. RESULTS: Older age, male gender, histologic subtype, and high tumor grade predicted worse SSS at the time of diagnosis. After 1 year of survival, older age, male gender, and histologic subtype were no longer significant predictors of conditional survival. Only high grade tumors remained a significant predictor of worse prognosis after 5 years of survival (HR 1.95). CONCLUSIONS: This population-based study demonstrates that the factors which are predictive of survival at baseline lose significance after one year of survival. Conditional survival estimates allow clinicians to provide survivors with more meaningful prognostic estimates that may impact surveillance schedules and streamline adjuvant therapy decisions and design of future clinical trials.
Authors: Alex B Blair; Bradley N Reames; Jasvinder Singh; Faiz Gani; Heidi N Overton; Robert J Beaulieu; Ying W Lum; James H Black; Fabian M Johnston; Nita Ahuja Journal: J Surg Oncol Date: 2018-06-07 Impact factor: 3.454
Authors: Richard J Straker; Yun Song; Adrienne B Shannon; Clayton T Marcinak; John T Miura; Douglas L Fraker; Giorgos C Karakousis Journal: Ann Surg Oncol Date: 2021-02-16 Impact factor: 5.344
Authors: Marcus C B Tan; Murray F Brennan; Deborah Kuk; Narasimhan P Agaram; Cristina R Antonescu; Li-Xuan Qin; Nicole Moraco; Aimee M Crago; Samuel Singer Journal: Ann Surg Date: 2016-03 Impact factor: 12.969
Authors: Marcus C B Tan; Jean M Butte; Mithat Gonen; Nancy Kemeny; Yuman Fong; Peter J Allen; T Peter Kingham; Ronald P Dematteo; William R Jarnagin; Michael I D'Angelica Journal: HPB (Oxford) Date: 2013-06-19 Impact factor: 3.647
Authors: Emily Z Keung; Nikita Rajkot; Keila E Torres; Neeta Somaiah; Kelly K Hunt; Barry W Feig; Christopher P Scally; Naruhiko Ikoma; Christina L Roland Journal: Ann Surg Oncol Date: 2020-05-14 Impact factor: 5.344
Authors: Dario Callegaro; Rosalba Miceli; Sylvie Bonvalot; Peter C Ferguson; Dirk C Strauss; Veroniek V M van Praag; Antonin Levy; Anthony M Griffin; Andrew J Hayes; Silvia Stacchiotti; Cecile Le Pèchoux; Myles J Smith; Marco Fiore; Angelo Paolo Dei Tos; Henry G Smith; Charles Catton; Joanna Szkandera; Andreas Leithner; Michiel A J van de Sande; Paolo G Casali; Jay S Wunder; Alessandro Gronchi Journal: EClinicalMedicine Date: 2019-11-22